Blogs about: Treatment Management

Featured Blog

Prostate only vs. whole pelvis radiotherapy for locally advanced and aggressive disease

If a patient is diagnosed with either high-risk prostate cancer that appears to be confined to the prostate or potentially locally advanced disease that may have progressed into nearby pelvic tissues,… more →

THE "NEW" PROSTATE CANCER INFOLINK

Prostate only vs. whole pelvis radiotherapy for locally advanced and aggressive disease

Sitemaster wrote 1 hour ago: If a patient is diagnosed with either high-risk prostate cancer that appears to be confined to the p … more →

Tags: Management, Port, prostate only radiotherapy, whole pelvis radiotherapy, WPRT

Prostate cancer radiotherapy in men on warfarin or Plavix

Sitemaster wrote 1 hour ago: A recent study has assessed the risk of bleeding as a consequence of radiation therapy for localized … more →

Tags: Management, anticoagulant, bleeding, clopidogrel, EBRT, external beam radiation, Risk, warfarin

Risk for metastasis post-surgery: a prognostic algorithm

Sitemaster wrote 1 day ago: A media release issued last Wednesday from the Sidney Kimmel Comprehensive Cancer Center at Johns Ho … more →

Tags: Living with Prostate Cancer, Management, Metastasis, prognosis, Surgery

Palliative prostate-specific radiotherapy in men with advanced prostate cancer

Sitemaster wrote 1 day ago: It is still not unusual, in large parts of the world, for patients to be diagnosed with prostate can … more →

Tags: Living with Prostate Cancer, Management, Localized, palliation, Radiotherapy, symptoms

Prostatectomy in patients with PSA > 20 ng/ml

Sitemaster wrote 1 day ago: Some years have passed since D’Amico and colleagues developed their risk classification system … more →

Tags: Diagnosis, Management, Risk, High Risk, patients, Surgery

Early data from a significant UK series of HIFU patients

Sitemaster wrote 2 days ago: Data have just been published on a series of 172 patients with organ-confined prostate cancer treate … more →

Tags: Management, HIFU, high-intensity focused ultrasound

ADT and changes in cognitive performance — 1 comment

Sitemaster wrote 3 days ago: A new — but very small and short-term study — has attempted to assess the baseline preva … more →

Tags: Living with Prostate Cancer, Management, Hormone, androgen deprivation, Therapy, function, Cognitive, Performance

Prostate cancer news reports: Wednesday, July 1, 2009

Sitemaster wrote 3 days ago: In today’s news reports we cover items on: Prediction of risk for prostate cancer under-gradi … more →

Tags: Diagnosis, Drugs in development, Management, Risk, biopsy, capecitabine, CRPC, docetaxel, Gleason score

Prostate cancer news reports: Tuesday, June 30, 2009

Sitemaster wrote 4 days ago: In todayas news reports we deal with items about: Celecoxib therapy prior to radical prostatectomy … more →

Tags: Diagnosis, Management, Living with Prostate Cancer, Drugs in development, Risk, Surgery, Lymph Node, Dissection, - Sentinel

Risks from selenium -- in men WITH prostate cancer — 5 comments

Sitemaster wrote 6 days ago: A recent study from researchers at the University of California, San Francisco and the Dana-Farber C … more →

Tags: Diagnosis, Living with Prostate Cancer, Management, Risk, Risk, selenium, sod2, superoxide dismutase

Prostate cancer news reports: Saturday, June 27, 2009

Sitemaster wrote 1 week ago: Today’s news reports deal with such items as: Genomic testing for prostate cancer and the val … more →

Tags: Diagnosis, Living with Prostate Cancer, Management, Risk, brachytherapy, Genome, MRI, MRSI, prognosis

Prostate cancer news reports: Friday, June 26, 2009 — 2 comments

Sitemaster wrote 1 week ago: Today’s prostate cancer news report summary includes items dealing with: The epigenetics of p … more →

Tags: Prevention, Diagnosis, Management, Risk, selenium, brachytherapy, Vitamin E, EBRT, Lycopene

All pumped up about PARPs

Sitemaster wrote 1 week ago: A report in this week’s issue of the New England Journal of Medicine (which is never shy about … more →

Tags: Drugs in development, Management, MSI-201, olaparib, PAP inhibitor

Proton beam vs. intensity-modulated RT: out on the battle lines — 3 comments

Sitemaster wrote 1 week ago: The relative merits of proton beam radiotherapy (PBRT) and the more commonly available intensity-mod … more →

Tags: Management, Cancer, IMRT, intensity-modulated, pbrt, proton beam, Radiation, second, Therapy

Prostate cancer news reports: Wednesday, June 24, 2009 — 3 comments

Sitemaster wrote 1 week ago: Today’s news reports include discussion of items on: Prostate cancer risk awareness Improving … more →

Tags: Prevention, Diagnosis, Management, Drugs in development, Risk, brachytherapy, Cryotherapy, Therapy, Risk

OGX-011 to enter Phase III trials for CRPC

Sitemaster wrote 1 week ago: OncoGenex Pharmaceuticals has just announced today that the company is “ready to proceed with … more →

Tags: Drugs in development, Management

Second pathologic opinions: do they change patient management?

Sitemaster wrote 1 week ago: We have long known that prostate cancer specimens (and specimens for other urologic malignancies) ca … more →

Tags: Diagnosis, Management

LRP in a contemporary group of low-risk prostate cancer patients

Sitemaster wrote 1 week ago: A group in the UK has published data on the outcomes of a large, contemporary cohort of patients wit … more →

Tags: Management, active surveillance, laparoscopic, low risk, Outcomes, Surgery, upstaging

Prostate cancer news reports: Tuesday, June 23, 2009

Sitemaster wrote 1 week ago: Today’s news reports address items on: Outcomes from different types of radical prostatectomy … more →

Tags: Diagnosis, Management, Living with Prostate Cancer, radical prostatectomy, Outcomes, Chemotherapy, external beam radiotherapy, Age, Second Line


Have your say. Start a blog.

See our free features →

Related Tags
All →

Follow this tag via RSS

Find other items tagged with “treatment-management”:
Technorati Del.icio.us IceRocket